PMID: 8607567Oct 1, 1995Paper

Cutaneous-mucosal allergic contact reaction due to topical corticosteroids

Allergy
M A Gonzalo Garijo, P Bobadilla González

Abstract

We report the case of a 41-year-old nonatopic women with a previous history of eczematous reaction due to hydrocortisone who suffered worsening of her perennial rhinitis in association with perinasal dermatitis from the use of budesonide in nasal spray form, and stomatitis and pharyngitis due to budesonide in a bronchial inhaler. Patch tests with a series of 25 corticosteroids, some of them at different concentrations and in different vehicles, were positive to tixocortol pivalate, hydrocortisone, budesonide, prednisolone, hydrocortisone butyrate propionate, triamcinolone acetonide, and fluocinolone acetonide. For some of them, a 1% solution in ethanol gave a positive reaction when a 20% mixture in petrolatum did not. Like other authors, we suggest that some multiple positives may represent sensitization to several steroids independently, true cross-reactions, or both, and that ethanol is a better vehicle than petrolatum.

References

Dec 1, 1992·Allergy·J Sastre, M D Ibañez
Feb 1, 1992·Contact Dermatitis·R HayakawaO Hirose
Jul 1, 1992·Contact Dermatitis·A FariaC de Freitas
Nov 1, 1992·The British Journal of Dermatology·A D Burden, M H Beck
Mar 1, 1992·Contact Dermatitis·A Dooms-Goossens, M Morren
Mar 1, 1992·Contact Dermatitis·A Dooms-GoossensR Kinget
Jan 1, 1992·Contact Dermatitis·S M Wilkinson, J S English
Feb 1, 1991·Journal of the American Academy of Dermatology·A I LauermaH I Maibach
Feb 1, 1991·Contact Dermatitis·R HayakawaO Hirose
Jul 1, 1991·Contact Dermatitis·H NodaH Ueda
Jan 1, 1991·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·M Murrieta-AguttesJ Dry
Feb 1, 1991·The Journal of Allergy and Clinical Immunology·A Peris-TortajadaA Basomba
Jan 1, 1991·Contact Dermatitis·B M PiracciniA Tosti
Apr 1, 1990·Contact Dermatitis·J JerezS Duque
Sep 1, 1989·Journal of the American Academy of Dermatology·A E Dooms-GoossensS A Coopman
Jul 1, 1989·The British Journal of Dermatology·S CoopmanA Dooms-Goossens
Apr 1, 1986·Contact Dermatitis·B Meding, E Dahlberg
Dec 1, 1980·Contact Dermatitis·E van Hecke, L Temmerman
Apr 1, 1994·Contact Dermatitis·M CorazzaA Virgili
Sep 1, 1994·The Journal of Allergy and Clinical Immunology·A Iglesias-CadarsoP Hernandez-Weigand
Jan 1, 1994·The British Journal of Dermatology·A Dooms-GoossensH Degreef
Jan 1, 1994·Clinical and Experimental Dermatology·S M Wilkinson
Mar 1, 1993·Contact Dermatitis·T HisaT Hamada
Mar 1, 1993·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A H LauermaA L Lauerma
Apr 1, 1993·The British Journal of Dermatology·L Räsänen, T Hasan
Apr 1, 1993·Contact Dermatitis·H NodaM Masutani
Apr 1, 1993·Contact Dermatitis·G JorroA Peláez

❮ Previous
Next ❯

Citations

Nov 9, 2002·Contact Dermatitis·M IsakssonS M Wilkinson
Aug 9, 2003·Expert Opinion on Drug Safety·Bernard Guillot
Jul 6, 2005·Dermatitis : Contact, Atopic, Occupational, Drug·Marléne Isaksson, Magnus Bruze
Dec 31, 1997·Contact Dermatitis·M IsakssonA Goossens
Sep 10, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rami Jean Salib, Peter Hugo Howarth
Jun 23, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M Isaksson
Nov 13, 2001·American Journal of Clinical Dermatology·B Guillot
Dec 24, 2005·Allergologia et immunopathologia·S CadinhaM G Castel-Branco
Nov 15, 2001·The Journal of Allergy and Clinical Immunology·J BousquetUNKNOWN World Health Organization

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.